Share on PinterestHeart disease is the leading cause of death for both males and females, despite the myth that heart disease is a “man’s disease.” Marco Govel/Stocksy Most women are unaware of their heart disease risks. The myth that heart disease is a ‘man’s disease’ is inaccurate as heart disease is the number one cause […]
Read MoreMonth: February 2026
Hair Extensions May Contain Cancer-Causing Chemicals, Study Finds
Share on PinterestRecent research has found that many hair extensions may contain chemicals that are linked to cancer. Image Credit: Vera Lair/Stocksy A new study has found that many types of hair extensions contain chemicals linked to cancer. A chemical banned from boat paint because it’s too toxic for fish is allowed in products worn […]
Read MoreHigh-Quality Low Carb, Low Fat Diet May Lower Cardiovascular Risk
Share on PinterestNew research indicates that diet quality matters for cardiovascular health. Nikolay_Donetsk/Getty Images The quality of a low carb or low fat diet may be more important for heart health than the amount of fat and carbohydrates consumed. Healthy versions of low fat and low carb diets that prioritized plant-based foods, whole grains, and […]
Read MoreFeasibility and cost-effectiveness of at-home self-sampling screening for type 2 diabetes: a pilot screening study in Denmark
Objective The increased use of HbA1c as a diagnostic criterion, novel methods to collect and store blood samples as well as the quality of national registers enable screening targeted individuals, who are not screened opportunistically. The study evaluates whether screening for type 2 diabetes using at-home self-sampling HbA1c tests, targeted people who have not had […]
Read MoreHair Extensions May Contain Cancer-Causing Chemicals, Study Finds
Share on PinterestRecent research has found that many hair extensions may contain chemicals that are linked to cancer. Image Credit: Vera Lair/Stocksy A new study has found that many types of hair extensions contain chemicals linked to cancer. A chemical banned from boat paint because it’s too toxic for fish is allowed in products worn […]
Read MoreEPCs-derived exosomal miR-7116-3p alleviate high glucose-induced endothelial cell dysfunction by targeting Orai1-IGFBP3 complexes
Introduction Diabetic vascular complications are predominantly caused by high glucose (HG)-induced endothelial dysfunction. Exosomes derived from endothelial progenitor cells (EPCs-EXOs) have shown therapeutic potential by modulating cellular functions through the delivery of bioactive cargos, particularly microRNAs (miRNAs). This study examines the role of EPCs-EXOs and their miRNA cargo in mitigating HG-induced endothelial dysfunction by targeting […]
Read MoreSpecial Edition – Oral GLP-1 Receptor Agonist
In this special series on Oral GLP-1 Receptor Agonists, Dr. Neil Skolnik will discuss the first of the GLP-1 RAs to receive FDA approval, Semaglutide. This special episode is supported by an independent educational grant from Novo. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; […]
Read MoreAerobic Exercise Highly Effective for Depression and Anxiety: Study
Share on PinterestA new study found that aerobic exercise may be as effective as standard treatments for depression and anxiety. Christine La/Stocksy A new study found that aerobic exercise can be highly effective for reducing symptoms of depression and anxiety, with benefits comparable to standard treatments. Group-based exercise provides the strongest relief for depression, offering […]
Read MoreFDA Blocks Hims & Hers $49 Compounded Wegovy Pill: What to Know
Share on PinterestHims & Hers has withdrawn its low cost compounded weight loss pill after pressure from top U.S. health officials and a major lawsuit. Image courtesy of Novo Nordisk Hims & Hers recently announced a $49 compounded semaglutide pill, offering a low cost alternative to the new Wegovy pill. However, the compounded version was […]
Read MoreEnhancing evidence-based care using trial emulation in electronic health records: real-world effects of empagliflozin in people with type 2 diabetes
Background There is growing interest in widening the use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) to all people with type 2 diabetes mellitus (T2DM). However, pivotal randomized controlled trials (RCTs) evaluated these drugs only in highly selected populations, often lacking generalizability to real-world populations. Understanding the effects of SGLT2i in populations where RCT evidence may […]
Read More